We created an internal team of clinical scientists, many of whom joined PMI from the pharmaceutical industry.
Aligned with the processes followed by the pharmaceutical industry, our studies are conducted by experienced Contract Research Organizations (CROs) who also conduct studies for pharmaceutical companies. An Institutional Review Board or Ethics Committee reviews, approves and monitors each of our studies, serving an important role in the protection of the rights and welfare of participants.
The details about all of the clinical studies we are conducting and have conducted are published on the largest online repository of clinical studies, www.clinicaltrials.gov. The results from the study are also published once the data is obtained and the study reports are finalized.
All of our clinical studies comply with the internationally recognized requirements of the International Conference of Harmonization’s Good Clinical Practice (ICH-GCP). This dictates the quality standards for designing, conducting and reporting our studies, as well as for protecting the safety and well-being of study participants.
All study participants are recruited through our partner CROs. All participants undergo a process of informed consent and selection by the principal investigator using pre-defined inclusion and exclusion criteria as defined in the study protocol.
Read more on the International Conference of Harmonization’s Good Clinical Practice
International Conference of Harmonization’s Good Clinical Practice Current Step 4 version 10 June 1996